Latest News for: metabolic disease

Edit

Poor Sleep Linked To Advanced Stages of Complex Heart & Kidney Disease Syndrome

Mega Doctor News 26 Mar 2025
Because this was a cross-sectional study – which provides a snapshot of a single moment in time – “this study can say zero about any directional causality between sleep and metabolic disease,” he said.
Edit

Science! SDU Researchers Identified the Membrane Receptor for Ceramide in Adipocytes

Knoxville Daily Sun 26 Mar 2025
These findings advance the understanding of ceramide's biological functions and open new avenues for developing targeted therapies against metabolic diseases.
Edit

Bạch Mai Hospital and AstraZeneca work together to improve patient care quality

Vietnam News 26 Mar 2025
... towards a comprehensive and sustainable direction, particularly in managing diseases related to oncology, respiratory, gastroenterology, cardiovascular, renal and metabolic disorders.”.
Edit

This Coffee Brewing Method Could Elevate Your Cholesterol Levels; Here's What You Should Do

NDTV 26 Mar 2025
The study published in the journal Nutrition, Metabolism & Cardiovascular Diseases mentions that boiled coffee contains elevated levels of cholesterol-boosting compounds ... .
Edit

Case Study Highlights INDIBA 448 kHz Radiofrequency’s Role in Visceral Fat Reduction and Prevention of Fat Accumulation

Vietnam News 26 Mar 2025
Visceral fat, the type that accumulates around internal organs, is known to be a significant contributor to serious health conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome.
Edit

Ancient microplant used in sewage treatment could be ‘the next big superfood’

New York Post 26 Mar 2025
“Proponents claim it may prevent and/or treat a multitude of health issues, including cancer, hepatitis C, nonalcoholic fatty liver disease, the common cold, asthma, lead toxicity, aging, ...
Edit

A self-described "fat" Salt Laker's journey toward fitness, one cycling class at a time.

Salt Lake City Weekly 26 Mar 2025
Regular aerobic exercise is the most important step a person can take to ward off cardiovascular diseases, like heart attacks and stroke ... "Many of our metabolic diseases are really exercise deficiency diseases," Klein noted.
Edit

Discovery Spark concludes with Protalea Bio named winner of Cancer Tech Accelerator spot

Pharmiweb 26 Mar 2025
Protalea Bio is pioneering cell therapies and bispecific biologics to tackle cancers and autoimmune diseases, particularly blood cancers, by targeting sphingolipid metabolism ... Dr ... https.//discovery-park.co.uk/discovery-spark/. .
Edit

New study results reinforce Tagrisso as the backbone therapy for EGFR-mutated lung cancer across stages and settings

Pharmiweb 26 Mar 2025
... development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.
Edit

Genflow Biosciences PLC Announces Institutional Investment

ACCESSWIRE 26 Mar 2025
... to explore the potential benefits of GF-1002 in treating MASH (Metabolic Dysfunction-Associated Steatohepatitis), the most prevalent chronic liver disease for which there is no effective treatments.
Edit

Is Ozempic a game-changer for insulin resistance? What you need to know

WPXI 25 Mar 2025
Insulin resistance is a growing health concern worldwide, linked to a variety of conditions such as type 2 diabetes, polycystic ovary syndrome (PCOS), Alzheimer's disease, metabolic syndrome, and cardiovascular disorders.
Edit

Biohacking comes of age

Deccan Herald 25 Mar 2025
This allows for the precise identification of geno-metabolic susceptibilities to conditions like type 2 diabetes, hypertension, obesity, cardiovascular diseases, cancers, COPD, dementia, anxiety, and depression.
Edit

The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist

Pharmiweb 25 Mar 2025
TUL is committed to strengthening its presence in the treatment of chronic diseases, including endocrine and metabolic disorders, while actively expanding its footprint in global markets.
×